e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Phenotyping asthma with biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Do volatile organic compounds (VOCs) discriminate between eosinophilic and neutrophilic asthma phenotype?
Florence Schleich (Liège, Belgium), Florence Schleich, Kirill Bessonov, Jan Dallinga, Virginie Paulus, Monique Henket, Agnes Boots, Agnieszka Smolinska, Emiel Wouters, Frederik-J. Van Schooten, Renaud Louis
Source:
International Congress 2015 – Phenotyping asthma with biomarkers
Session:
Phenotyping asthma with biomarkers
Session type:
Oral Presentation
Number:
1466
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Florence Schleich (Liège, Belgium), Florence Schleich, Kirill Bessonov, Jan Dallinga, Virginie Paulus, Monique Henket, Agnes Boots, Agnieszka Smolinska, Emiel Wouters, Frederik-J. Van Schooten, Renaud Louis. Do volatile organic compounds (VOCs) discriminate between eosinophilic and neutrophilic asthma phenotype?. Eur Respir J 2015; 46: Suppl. 59, 1466
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Can exhaled volatile organic compounds predict asthma exacerbations in children?
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Phenotypic characteristics of asthma with small airways involvement
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Characterisation of asthma patients with persistent airflow obstruction
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Clinical application of hydrogen sulfide (H2S) as a marker of asthma management
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Comparison of clinical features of severe persistent asthma and refractory asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Allergic versus non allergic asthma: What makes the difference?
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Application of clustering approach to occupational asthma due to isocyanates
Source: International Congress 2015 – Work, environment and the epidemiology of asthma
Year: 2015
Late-onset hypereosinophilic asthma accompanied by systemic eosinophilic manifestations
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Mast cell gene signature enrichment associates with late-onset severe asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Chronic rhinosinusitis with and without nasal polyps and rhinitis in adult asthma. Frequency distribution and relationship with asthma control and severity (the IRIS-ASMA study)
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Prevalence of refractory asthma in population with severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept